全球藥物傳輸設備市場

預計到 2030 年全球藥物輸送設備市場規模將達到 5.626 億美元

2024 年全球藥物輸送裝置市場規模估計為 4.049 億美元，預計到 2030 年將達到 5.626 億美元，在 2024-2030 年分析期內的複合年成長率為 5.6%。穿戴式注射器是報告中分析的細分市場之一，預計複合年成長率為 4.3%，到分析期結束時將達到 1.789 億美元。在分析期內，自動注射器部分的複合年成長率預計為 6.7%。

美國市場規模估計為 1.103 億美元，中國市場預計複合年成長率為 8.6%

預計 2024 年美國藥物輸送設備市場價值將達到 1.103 億美元。預計到 2030 年，作為世界第二大經濟體的中國市場規模將達到 1.118 億美元，2024-2030 年分析期間的複合年成長率為 8.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.9% 和 5.5%。在歐洲，德國的複合年成長率預計為 3.6%。

全球藥物輸送設備市場－主要趨勢與促進因素摘要

為什麼藥物輸送裝置將徹底改變慢性病管理和生物製藥管理？

肥胖相關藥物輸送裝置 (OBDD) 正在重新定義生技藥品和長效注射療法的管理，使患者能夠透過穿戴式的預編程系統在家中自行管理治療。這些裝置貼在皮膚上，可以在幾分鐘到幾小時內輸送藥物，取代頻繁的就診和皮下或靜脈注射。 OBDD 的興起與需要長期藥物治療的慢性疾病的盛行率不斷上升相吻合，這些疾病包括癌症、糖尿病、自體免疫疾病和心血管疾病。

對 OBDD 的需求是由向基於價值的護理的轉變所驅動的，其中醫療保健系統旨在透過分散的護理模式來降低住院費用並改善患者的生活品質。 OBDD 具有減少給藥頻率、改善藥物動力學和提高患者依從性的好處。 OBDD 在腫瘤學和免疫學領域尤其具有吸引力，因為可以透過皮下注射單株抗體、查核點抑制劑和細胞激素療法。將這些設備整合到數位健康生態系統中將進一步支援遠端監控、即時依從性追蹤和最佳化臨床結果。

設計創新和數位整合如何提高人體遞送平台的效用和可接受性？

現代藥物輸送裝置採用先進的電子設備、微流體幫浦和穿戴式材料設計，確保易用性、安全性和病患舒適度。大多數設備都是一次性使用的電池供電系統，包括整合黏性貼片、自動藥物重構機制以及用於指示狀態和完成情況的聲音/視覺指示器。緊湊的外形規格、可自訂的給藥方案和溫度控制功能擴大了各種藥物類型和患者群體的易用性。

OBDD 與數位療法和互聯健康平台的日益整合是創新的關鍵領域。支援藍牙的 OBDD 現在可以將管理確認、時間戳記和裝置診斷傳輸到行動應用程式或雲端基礎的醫生入口網站。這種連結將實現個人化的劑量提醒、不利事件報告和不遵守規定介入。人工智慧主導的分析將應用於利用率數據，以預測給藥延遲、增強治療個人化並識別高風險患者群體。這些智慧功能正在將 OBDD 從被動設備轉變為更廣泛的護理範圍內的動態工具。

哪些治療領域和地理市場正在加速採用內部藥物傳輸系統？

體內藥物傳遞的最大應用領域是腫瘤學，特別是用於乳癌、肺癌和骨髓惡性腫瘤的單株抗體療法。安進公司的 Neulasta Onpro 等設備透過消除重返醫院的需要並改善化療後獲得支持性護理的機會，顯示出強大的市場滲透力。類風濕性關節炎、克隆氏症和乾癬等免疫系統疾病也是一個主要市場，Adalimumab和Ustekinumab等生物製藥已被應用於穿戴式裝置。

由於生物製藥的廣泛採用、優惠的報銷制度和良好的組合藥物監管框架，北美在市場中處於領先地位。緊隨其後的是歐洲，這得益於慢性病的流行和居家醫療系統的擴展。亞太地區是一個成長前沿，尤其是日本和韓國，那裡的老齡化社會和先進的製藥基礎設施為 OBDD 的採用創造了有利條件。在新興市場，與製藥公司的夥伴關係以及支持遠端醫療的推廣計劃正在幫助縮小獲取醫療服務的差距，使 OBDD 成為社區級慢性病護理模式的關鍵組成部分。

什麼將推動藥物輸送裝置市場的長期成長和策略創新？

藥物輸送裝置市場的成長受到生物製藥使用量的增加、以患者為中心的護理模式的不斷發展以及減輕醫療保健系統負擔的需求的推動。 COVID-19 疫情加速了向自我治療的轉變，並凸顯了 OBDD 在確保系統中斷期間護理連續性方面的重要性。付款人對基於結果的報銷的興趣增加也推動了採用技術來提高依從性和現實世界的有效性。

設備製造商正在投資支援各種體積、黏度和藥物穩定性的模組化平台。在環境審查中，永續設計（包括可回收零件和減少塑膠使用）變得越來越重要。生技公司和醫療設備製造商之間的共同開發夥伴關係正在成為常態，使得藥物-醫療設備組合能夠更快地獲得核准並進入市場。生物製藥繼續主導醫藥管道，數位健康成為慢性病管理不可或缺的一部分，內部輸送設備將發展成為多功能、智慧的健康伴侶，將專科護理的範圍擴展到傳統臨床環境之外。

部分

產品類型（穿戴式注射器、自動注射器、貼片、其他產品類型）、應用（心血管疾病應用、癌症應用、自體免疫疾病應用、糖尿病應用、其他應用）、最終用途（醫院最終用途、專科診所最終用途、門診手術中心最終用途、其他最終用途）

受訪公司範例（值得關注的32家公司）

• Ablitech, Inc.
• BD（Becton, Dickinson and Company）
• BioSapien Inc.
• Coherus BioSciences, Inc.
• Convatec Group plc
• Eitan Medical
• Elcam Medical
• Enable Injections
• Gerresheimer AG
• Intarcia Therapeutics
• Johnson & Johnson
• Medtronic plc
• Nemera
• NOVO Engineering
• Phillips-Medisize
• Roche Holding AG
• SHL Medical
• Stevanato Group
• Tandem Diabetes Care, Inc.
• Ypsomed AG

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口（成品和OEM）預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、降低盈利、重組供應鏈等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家（14,949）、智庫（62）和貿易及產業協會（171）的專家意見，以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計，這種動盪將在未來幾個月內平息，新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月：談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響，並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家，他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global On-Body Drug Delivery Devices Market to Reach US$562.6 Million by 2030

The global market for On-Body Drug Delivery Devices estimated at US$404.9 Million in the year 2024, is expected to reach US$562.6 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Wearable Injectors, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$178.9 Million by the end of the analysis period. Growth in the Auto-injectors segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$110.3 Million While China is Forecast to Grow at 8.6% CAGR

The On-Body Drug Delivery Devices market in the U.S. is estimated at US$110.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$111.8 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global On-Body Drug Delivery Devices Market - Key Trends & Drivers Summarized

Why Are On-Body Drug Delivery Devices Revolutionizing Chronic Disease Management and Biologic Administration?

On-body drug delivery devices (OBDDs) are redefining the administration of biologics and long-acting injectable therapies by enabling patients to self-administer treatments in a home setting through wearable, pre-programmed systems. These devices are adhered to the skin and deliver medications over minutes to hours, offering an alternative to frequent hospital visits, subcutaneous injections, or intravenous infusions. Their rise coincides with the increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions that require long-term pharmacologic adherence.

The demand for OBDDs is being driven by the shift toward value-based care, where healthcare systems aim to reduce hospitalization costs and improve patient quality of life through decentralized treatment models. These devices offer benefits such as reduced dosing frequency, improved pharmacokinetics, and enhanced patient compliance. Their appeal is particularly strong in oncology and immunology, where monoclonal antibodies, checkpoint inhibitors, and cytokine therapies can be delivered subcutaneously using OBDDs. The integration of these devices into digital health ecosystems further supports remote monitoring, real-time adherence tracking, and clinical outcome optimization.

How Are Design Innovations and Digital Integration Enhancing the Utility and Acceptance of On-Body Delivery Platforms?

Modern on-body drug delivery devices are engineered with advanced electronics, microfluidic pumps, and wearable-friendly materials to ensure ease of use, safety, and patient comfort. Most devices are single-use, battery-powered systems that include integrated adhesive patches, automated drug reconstitution mechanisms, and audible/visual indicators for status and completion. Compact form factors, customizable dosing regimens, and temperature control functionalities are expanding usability across diverse drug types and patient demographics.

The growing convergence of OBDDs with digital therapeutics and connected health platforms is a key innovation area. Bluetooth-enabled OBDDs can now transmit dose confirmation, time stamps, and device diagnostics to mobile apps or cloud-based physician portals. Such connectivity allows for personalized dosing reminders, adverse event reporting, and intervention for non-adherence. AI-driven analytics are being applied to usage data to predict dose delays, enhance treatment personalization, and identify high-risk patient cohorts. These smart capabilities are transforming OBDDs from passive devices into dynamic tools within the broader continuum of care.

Which Therapeutic Areas and Regional Markets Are Accelerating the Adoption of On-Body Drug Delivery Systems?

The oncology sector is the largest application area for on-body drug delivery, especially for monoclonal antibody therapies used in breast cancer, lung cancer, and hematologic malignancies. Devices like Amgen’s Neulasta Onpro have demonstrated strong market penetration by improving access to post-chemotherapy supportive care without requiring hospital return visits. Immunological disorders-such as rheumatoid arthritis, Crohn’s disease, and psoriasis-also represent major markets, with biologics like adalimumab and ustekinumab increasingly reformulated for wearable delivery.

North America leads the market due to high biologic adoption, strong reimbursement frameworks, and favorable regulatory pathways for combination products. Europe follows closely, supported by chronic disease prevalence and homecare system expansion. Asia-Pacific is a growing frontier, particularly in Japan and South Korea, where aging populations and advanced pharmaceutical infrastructure are creating favorable conditions for OBDD adoption. In emerging markets, pharma partnerships and telehealth-enabled outreach programs are helping to bridge accessibility gaps, positioning OBDDs as a key component in community-level chronic care models.

What Is Driving Long-Term Growth and Strategic Innovation in the On-Body Drug Delivery Devices Market?

The growth in the on-body drug delivery devices market is driven by rising biologic usage, evolving patient-centric care models, and the need to reduce healthcare system burdens. The COVID-19 pandemic accelerated the shift to self-administered treatments, highlighting the relevance of OBDDs in ensuring continuity of care during system disruptions. Increasing payer interest in outcomes-based reimbursement is also prompting adoption of technologies that improve adherence and real-world efficacy.

Device manufacturers are investing in modular platforms that support a range of volumes, viscosities, and drug stabilities. Sustainable design-including recyclable components and reduced plastic use-is gaining importance amid environmental scrutiny. Co-development partnerships between biotech companies and device manufacturers are becoming standard, enabling drug-device combination products to achieve faster regulatory clearance and market entry. As biologics continue to dominate pharmaceutical pipelines, and as digital health becomes integral to chronic disease management, on-body delivery devices will evolve into multifunctional, intelligent health companions that extend the reach of specialty care beyond traditional clinical settings.

SCOPE OF STUDY:

The report analyzes the On-Body Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Wearable Injectors, Auto-injectors, Patches, Other Product Types); Application (Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Ablitech, Inc.
• BD (Becton, Dickinson and Company)
• BioSapien Inc.
• Coherus BioSciences, Inc.
• Convatec Group plc
• Eitan Medical
• Elcam Medical
• Enable Injections
• Gerresheimer AG
• Intarcia Therapeutics
• Johnson & Johnson
• Medtronic plc
• Nemera
• NOVO Engineering
• Phillips-Medisize
• Roche Holding AG
• SHL Medical
• Stevanato Group
• Tandem Diabetes Care, Inc.
• Ypsomed AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • On-Body Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Patient-Centric Drug Delivery Drives Growth in On-Body Wearable Devices
  • Increase in Biologic Drug Approvals Spurs Adoption of Large-Volume Subcutaneous Delivery Systems
  • Expansion of Home-Based Care Models Strengthens Business Case for Self-Administered On-Body Devices
  • Surge in Chronic Disease Prevalence Throws the Spotlight on Long-Term and Sustained Drug Delivery Technologies
  • Advancements in Smart Wearable Injectors Drive Real-Time Monitoring and Dosing Precision
  • Rising Regulatory Support for Connected Devices Enhances Market Readiness for Digital Health Integration
  • Availability of Integrated Sensors and Alarms Improves Compliance and Enhances Patient Safety
  • Shift Toward Prefilled, Disposable Systems Propels Demand for Low-Maintenance Drug Delivery Solutions
  • Growth in Oncology and Immunotherapy Treatments Supports Expansion of On-Body Device Pipelines
  • Increasing Pharmaceutical-Biotech Collaborations Enable Co-Development of Drug-Device Combinations
  • Adoption of Wearable Patch Pumps in Diabetes Management Expands Use in Adjacent Therapeutic Areas
  • Supply Chain Optimization and Device Standardization Drive Cost-Efficient Mass Production
  • Challenges in Battery Life and Device Adhesion Highlight Opportunities for Technical Innovation
  • Global Emphasis on Reducing Hospital Readmissions Supports Shift to Ambulatory Drug Delivery Models
  • Use of Connectivity and Cloud Platforms Facilitates Integration With EHR and Remote Monitoring Systems
  • Growing Investment in Human Factors Engineering Enhances User-Friendly Device Design
  • Demand for Reduced Injection Frequency Enhances Uptake of Long-Acting On-Body Delivery Formats
  • Regulatory Focus on Post-Market Surveillance and Real-World Data Strengthens Adoption Confidence
  • Rising Patient Awareness and Tech Literacy Levels Expand Market Acceptance of On-Body Delivery Platforms
  • Expansion of CDMO Services for Drug-Device Combination Products Accelerates Go-to-Market Strategy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World On-Body Drug Delivery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for On-Body Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Auto-injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Auto-injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Auto-injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for On-Body Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for On-Body Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for On-Body Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • On-Body Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for On-Body Drug Delivery Devices by Product Type - Wearable Injectors, Auto-injectors, Patches and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for On-Body Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Wearable Injectors, Auto-injectors, Patches and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for On-Body Drug Delivery Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for On-Body Drug Delivery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for On-Body Drug Delivery Devices by Application - Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for On-Body Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Cancer Application, Autoimmune Diseases Application, Diabetes Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION